# A Study to Assess Any Potential Interaction Between Colesevelam and Ciclosporin in Healthy Volunteers

> **NCT00692250** · PHASE1 · COMPLETED · sponsor: **Genzyme, a Sanofi Company** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Colesevelam hydrochloride film-coated tablets (Cholestagel)

## Key facts

- **NCT ID:** NCT00692250
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2015-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00692250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00692250, "A Study to Assess Any Potential Interaction Between Colesevelam and Ciclosporin in Healthy Volunteers". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00692250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*